We are live on ! Find out more
REGN icon

Regeneron Pharmaceuticals
REGN

371 hedge funds and large institutions have $17B invested in Regeneron Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 371 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more call options, than puts

Call options by funds: $300M | Put options by funds: $263M

Holders
371
Holders Change
+371
Holders Change %
–
% of All Funds
12.11%
Holding in Top 10
9
Holding in Top 10 Change
+9
Holding in Top 10 Change %
% of All Funds
0.29%
New
371
Increased
–
Reduced
–
Closed
–
Calls
$300M
Puts
$263M
Net Calls
+$37.1M
Net Calls Change
+$37.1M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HMS
226
Hanseatic Management Services
New Mexico
$1.73M +$1.79M +7,672 New
CBOA
227
Commonwealth Bank of Australia
Australia
$1.72M +$1.78M +7,630 New
GIA
228
Gateway Investment Advisers
Ohio
$1.64M +$1.7M +7,296 New
FCBT
229
First Citizens Bank & Trust
North Carolina
$1.6M +$1.66M +7,116 New
KeyBank National Association
230
KeyBank National Association
Ohio
$1.56M +$1.61M +6,923 New
SAM
231
Securian Asset Management
Minnesota
$1.51M +$1.57M +6,730 New
DWA
232
Douglass Winthrop Advisors
New York
$1.47M +$1.53M +6,550 New
M&T Bank
233
M&T Bank
New York
$1.43M +$1.48M +6,376 New
Nordea Investment Management
234
Nordea Investment Management
Sweden
$1.4M +$1.45M +6,240 New
AG
235
Aperio Group
California
$1.38M +$1.42M +6,119 New
KIA
236
Kopp Investment Advisors
Minnesota
$1.34M +$1.39M +5,963 New
OPERF
237
Oregon Public Employees Retirement Fund
Oregon
$1.29M +$1.33M +5,726 New
GH
238
GAM Holding
Switzerland
$1.26M +$1.3M +5,588 New
Canada Pension Plan Investment Board
239
Canada Pension Plan Investment Board
Ontario, Canada
$1.19M +$1.23M +5,303 New
PCM
240
Prelude Capital Management
New York
$1.17M +$1.21M +5,184 New
Group One Trading
241
Group One Trading
Illinois
$1.15M +$1.19M +5,102 New
PAM
242
Panagora Asset Management
Massachusetts
$1.11M +$1.15M +4,925 New
WCM
243
Winton Capital Management
United Kingdom
$1.08M +$1.12M +4,791 New
TMAM
244
Tokio Marine Asset Management
Japan
$1.05M +$1.09M +4,682 New
WBC
245
Westpac Banking Corp
Australia
$1.04M +$1.16M +4,982 New
PI
246
Putnam Investments
Massachusetts
$1.02M +$1.06M +4,537 New
ARTA
247
A.R.T. Advisors
New York
$1.01M +$1.05M +4,513 New
SCM
248
Stux Capital Management
New York
$1.01M +$1.05M +4,500 New
WT
249
Wilmington Trust
Delaware
$994K +$1.03M +4,422 New
EA
250
Emerald Advisers
Pennsylvania
$982K +$1.02M +4,368 New
8 9
10
11 12

REGN Hedge Fund Activity: Q2 2013 in Review

371 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Regeneron Pharmaceuticals (REGN) for Q2 2013, worth a combined $17B.

Buyers outnumbered sellers: 371 funds opened new REGN positions and 0 closed out — a net gain of 371 holders — while 0 added to existing stakes and 0 trimmed.

  • 371 institutional investors held Regeneron Pharmaceuticals (REGN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17B of Regeneron Pharmaceuticals stock for Q2 2013.
  • 371 funds opened new Regeneron Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +371 holders.

Based on aggregated 13F filings for Q2 2013.